WHAT: The Advanced Product Incubator (API) establishes cell-free platforms to develop regenerative therapies. Built according to Current Good Manufacturing Practices (CGMP) set forth by the Food and Drug Administration (FDA), the API adheres to rigorous standards of facility design, monitoring and process control. This multidisciplinary, first-of-its-kind facility bridges teams of researchers and physicians with scientific and industry experts to accelerate product development.read more
